Approved for SOMAVERT is indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery or radiation therapy, or for whom these therapies are not appropriate. The goal of treatment is to normalize serum insulin-like growth factor-1 (IGF-1) levels.. Pegvisomant selectively binds to growth hormone (GH) receptors on cell surfaces, where it blocks the binding of…
Loading full data from Know Your Drugs Institute…